XTL Biopharmaceuticals Ltd. (ADR) share price logo

XTL Biopharmaceuticals Ltd. (ADR)

NASDAQ: XTLB

$2.70

+0.21

(+8.43%)

as on

XTL Biopharmaceuticals Ltd. (ADR) Stock Performance

as on July 3, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.36
    $2.73
    downward going graph

    12.59%

    Downside

    1.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.01
    $10.28
    downward going graph

    25.55%

    Downside

    280.73%

    Upside

    downward going graph

XTL Biopharmaceuticals Ltd. (ADR) share price movements today

Previous Close
$2.49
Open
$2.44
Volume
293.4K
Day's Low - High
$2.36 - $2.73
52 Week Low - High
$2.01 - $10.28

XTL Biopharmaceuticals Ltd. (ADR) Historical Returns

1 Month Return
+ 19.47 %
3 Month Return
+ 11.11 %
1 Year Return
-48.86 %
3 Year Return
-32.5 %
5 Year Return
-82.87 %

XTL Biopharmaceuticals Ltd. (ADR) Stock Fundamentals & Key Indicators

Check XTL Biopharmaceuticals Ltd. (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.9M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-577.13%

XTL Biopharmaceuticals Ltd. (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of XTL Biopharmaceuticals Ltd. (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
XTL Biopharmaceuticals Ltd. (ADR) image
XTL Biopharmaceuticals Ltd. (ADR)
NA$5.9M-82.87%NA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.9B478.19%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$40.3B82.45%75.812.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$126.4B163.31%29.5935.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.5B12.1%15.2529.65%0.5700000000000001%

Stock Returns calculator for XTL Biopharmaceuticals Ltd. (ADR) Stock including INR - Dollar returns

The XTL Biopharmaceuticals Ltd. (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

XTL Biopharmaceuticals Ltd. (ADR) investment value today

Current value as on today

₹56,765

Returns

-₹43,235

(-43.23%)

Returns from XTL Biopharmaceuticals Ltd. (ADR) Stock

-₹48,864 (-48.86%)

Dollar Impact

₹5,629 (+5.63%)

Indian Investors' Interest in XTL Biopharmaceuticals Ltd. (ADR) Stock

Search interest for XTL Biopharmaceuticals Ltd. (ADR) Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-54% versus previous 30 day period

XTL Biopharmaceuticals Ltd. (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Total Revenue
0
-
-
-
-
-
-
0
0
0
Gross Profit
0
-
-
-
-
-
-
0
0
0
Operating Income
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
-
0
Interest Expense
0
0
0
0
-
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
0
0
0
0
0
0
0
0
0
0
Income Tax Expense
0
0
0
0
0
0
-
-
-
0
Net Income
0
0
0
0
0
0
0
0
0
0
Net Profit Margin
162.96%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-341.36%
-88.24%
-88.24%

XTL Biopharmaceuticals Ltd. (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
1
0
-
0
-
Gross Profit
0
0
0
0
0
0
0
-
0
-
Operating Income
-2
-1
0
0
0
-1
0
0
-2
-1
EBITDA
-1
-1
0
0
0
-1
0
0
0
-
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
0
-
-
0
0
0
-
0
-
Income Before Tax
-2
0
2
-1
-2
0
-1
-1
-1
0
Income Tax Expense
0
0
0
0
0
-1
0
0
0
-
Net Income
-2
0
2
-1
0
0
-1
0
-1
-6
Net Profit Margin
-11065.22%
-2693.10%
5742.31%
-1952.17%
-2792.86%
29.67%
293.68%
0.00%
-227.72%
0.00%

XTL Biopharmaceuticals Ltd. (ADR) Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Net Income
0
0
0
0
0
0
0
0
0
Operating Cash Flow
-
-
-
-
-
-
-
-
-
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
Change in Cash
0
0
0
-
-4
-
-
-
-

XTL Biopharmaceuticals Ltd. (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
2
-1
-2
0
-1
-1
-1
-6
Operating Cash Flow
-1
0
0
0
-1
0
0
-1
-1
Investing Cash Flow
-2
0
2
0
0
0
0
0
-
Financing Cash Flow
4
0
0
0
0
-
-
1
0
Change in Cash
1
0
1
0
0
0
0
-1
0

Global Institutional Holdings in XTL Biopharmaceuticals Ltd. (ADR)

Funds
Holdings
Noked Israel Ltd
2.1%
SmartHarvest Portfolios, LLC
0.56%
Rhumbline Advisers
0.25%
Tower Research Capital LLC
0.01%
XTX Topco Ltd
0%
See all

Insights on XTL Biopharmaceuticals Ltd. (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, XTLB stock has moved up by 14.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 622.3% return, outperforming this stock by 651.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 399.7% return, outperforming this stock by 448.6%

About XTL Biopharmaceuticals Ltd. (ADR)

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
OrganisationXTL Biopharmaceuticals Ltd. (ADR)
Headquarters26 Ben-Gurion St., Ramat Gan, Israel, 5112001
IndustryBiotechnology
CEOMr. Noam Band
E-voting on sharesClick here to vote

Key Management of XTL Biopharmaceuticals Ltd. (ADR)

Name

Title

Mr. Segal Niv CPA

Chief Financial Officer

Mr. Noam Band

CEO & Director

FAQs

What is XTL Biopharmaceuticals Ltd. (ADR) share price today?

XTL Biopharmaceuticals Ltd. (ADR) share price today is $2.70 as on at the close of the market. XTL Biopharmaceuticals Ltd. (ADR) share today touched a day high of $2.73 and a low of $2.36.

What is the 52 week high and 52 week low for XTL Biopharmaceuticals Ltd. (ADR) share?

XTL Biopharmaceuticals Ltd. (ADR) share touched a 52 week high of $10.28 on and a 52 week low of $2.01 on . XTL Biopharmaceuticals Ltd. (ADR) stock price today i.e. is closed at $2.70,which is 73.73% down from its 52 week high and 34.32% up from its 52 week low.

What is XTL Biopharmaceuticals Ltd. (ADR)'s market capitalisation today?

XTL Biopharmaceuticals Ltd. (ADR) market capitalisation is $0.00T as on .

How to invest in XTL Biopharmaceuticals Ltd. (ADR) Stock (XTLB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for XTL Biopharmaceuticals Ltd. (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in XTL Biopharmaceuticals Ltd. (ADR) Shares that will get you 0.5556 shares as per XTL Biopharmaceuticals Ltd. (ADR) share price of $2.70 per share as on July 3, 2026 at 8:46 am IST.

What is the minimum amount required to buy XTL Biopharmaceuticals Ltd. (ADR) Stock (XTLB) from India?

Indian investors can start investing in XTL Biopharmaceuticals Ltd. (ADR) (XTLB) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in XTL Biopharmaceuticals Ltd. (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on XTL Biopharmaceuticals Ltd. (ADR) share’s latest price of $2.70 as on July 3, 2026 at 8:46 am IST, you will get 3.7037 shares of XTL Biopharmaceuticals Ltd. (ADR). Learn more about fractional shares .

What are the returns that XTL Biopharmaceuticals Ltd. (ADR) has given to Indian investors in the last 5 years?

XTL Biopharmaceuticals Ltd. (ADR) stock has given -82.87% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?